Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.

Kim J, Lima E Silva R, Shmueli RB, Mirando AC, Tzeng SY, Pandey NB, Ben-Akiva E, Popel AS, Campochiaro PA, Green JJ.

Acta Biomater. 2019 Oct 1;97:451-460. doi: 10.1016/j.actbio.2019.07.054. Epub 2019 Jul 30.

PMID:
31374338
2.

Injectable drug depot engineered to release multiple ophthalmic therapeutic agents with precise time profiles for postoperative treatment following ocular surgery.

Mohammadi M, Patel K, Alaie SP, Shmueli RB, Besirli CG, Larson RG, Green JJ.

Acta Biomater. 2018 Jun;73:90-102. doi: 10.1016/j.actbio.2018.04.037. Epub 2018 Apr 21.

3.

Anisotropic biodegradable lipid coated particles for spatially dynamic protein presentation.

Meyer RA, Mathew MP, Ben-Akiva E, Sunshine JC, Shmueli RB, Ren Q, Yarema KJ, Green JJ.

Acta Biomater. 2018 May;72:228-238. doi: 10.1016/j.actbio.2018.03.056. Epub 2018 Apr 7.

4.

Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.

Bressler EM, Kim J, Shmueli RB, Mirando AC, Bazzazi H, Lee E, Popel AS, Pandey NB, Green JJ.

J Biomed Mater Res A. 2018 Jun;106(6):1753-1764. doi: 10.1002/jbm.a.36360. Epub 2018 Feb 23.

5.

Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.

Silva RLE, Kanan Y, Mirando AC, Kim J, Shmueli RB, Lorenc VE, Fortmann SD, Sciamanna J, Pandey NB, Green JJ, Popel AS, Campochiaro PA.

Sci Transl Med. 2017 Jan 18;9(373). pii: eaai8030. doi: 10.1126/scitranslmed.aai8030.

6.

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.

Shmueli RB, Ohnaka M, Miki A, Pandey NB, Lima e Silva R, Koskimaki JE, Kim J, Popel AS, Campochiaro PA, Green JJ.

Biomaterials. 2013 Oct;34(30):7544-51. doi: 10.1016/j.biomaterials.2013.06.044. Epub 2013 Jul 10.

7.
8.

Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo.

Kamat CD, Shmueli RB, Connis N, Rudin CM, Green JJ, Hann CL.

Mol Cancer Ther. 2013 Apr;12(4):405-15. doi: 10.1158/1535-7163.MCT-12-0956. Epub 2013 Jan 30.

9.

Gene delivery nanoparticles specific for human microvasculature and macrovasculature.

Shmueli RB, Sunshine JC, Xu Z, Duh EJ, Green JJ.

Nanomedicine. 2012 Oct;8(7):1200-7. doi: 10.1016/j.nano.2012.01.006. Epub 2012 Feb 1.

10.

A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles.

Bhise NS, Shmueli RB, Gonzalez J, Green JJ.

Small. 2012 Feb 6;8(3):367-73. doi: 10.1002/smll.201101718. Epub 2011 Dec 5. No abstract available.

11.

Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.

Bhise NS, Shmueli RB, Sunshine JC, Tzeng SY, Green JJ.

Expert Opin Drug Deliv. 2011 Apr;8(4):485-504. doi: 10.1517/17425247.2011.558082. Epub 2011 Feb 22. Review.

12.

Electrostatic surface modifications to improve gene delivery.

Shmueli RB, Anderson DG, Green JJ.

Expert Opin Drug Deliv. 2010 Apr;7(4):535-50. doi: 10.1517/17425241003603653. Review.

Supplemental Content

Loading ...
Support Center